This product is for research use only and is not for human consumption or therapeutic use.
CAS Number:
2169919-21-3
Purity:
99.88
Molecular Formula:
C32H47FN6O4S
Molecular Weight:
630.82
Alternative Names:
SNDX-5613
- Data sheet: View or download
- MSDS: View or download
- Protocol: View or download
Product Description:
Revumenib (SNDX-5613) is a potent and specific Menin-MLL inhibitor with a binding Ki of 0.149 nM and a cell based IC50 of 10-20 nM. Revumenib can be used for the research of MLL-rearranged (MLL-r) acute leukemias, including acute lymphoblastic leukemia (ALL) and acute myeloid leukemia (AML)[1].
Storage Temperature:
-20°C, 3 years; 4°C, 2 years (Powder)